Qibiao Wu

5.2k citations
147 papers · 2.6k indexed · 1 hit paper · h-index 30

Qibiao Wu

132 papers receiving 2.6k citations

Hit Papers

Luteolin and its derivative apigenin suppress the inducib...177202120262022202450100150

Peers

Qibiao Wu
Comparison fields: 5 of 132
  • Cancer Research 463
  • Complementary and alternative medicine 207
  • Pharmacology 214
  • Molecular Biology 1.2k
  • Oncology 453
Replace Hongzhong Li with:
Hongzhong Li China
Jun Gu China
Yifeng Zheng China
Heng Zhou China
Guang Liang China
Anjana Munshi India
Zhifeng Wei China
Ming‐Ju Hsieh Taiwan
Haitao Zhang China
Qibiao Wu relative to Hongzhong Li China Hongzhong Li's profile →
Citations per field
00.5×1.5×2.5×
Hongzhong Li · 1×
Citations per year

Countries citing papers authored by Qibiao Wu

Since Specialization
Citations

This map shows the geographic impact of Qibiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qibiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qibiao Wu more than expected).

Fields of papers citing papers by Qibiao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qibiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qibiao Wu. The network helps show where Qibiao Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Qibiao Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qibiao Wu Line = papers co-authored together Qibiao Wu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20250
4 20250
5 20245
6 20242
7 20247
8 20242
9 20246
10 20241
11 20236
12 20231
13 20232
14 20235
15 20238
16 202216
17 202045
18
Protective Effect of Artificial Musk Preconditioning on Rat Myocardial Ischemic and Reperfusion Injury
20101
19
Effects of artificial musk on hyperlipemia in rats
20101
20
Effect of artificial musk on myocardial ischemia in animals
20092

About Qibiao Wu

Qibiao Wu is a scholar working on Complementary and alternative medicine, Pharmacology and Cancer Research, having authored 147 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Traditional Chinese Medicine Analysis (12 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Cancer-related molecular mechanisms research (7 papers), Plant-based Medicinal Research (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). The work is most often cited by research in Cancer Research (463 citations), Complementary and alternative medicine (207 citations) and Pharmacology (214 citations). Qibiao Wu has collaborated with scholars based in Macao, China and United States. Frequent co-authors include Elaine Lai‐Han Leung, Xing‐Xing Fan, Xinbing Sui, Cong Xu, Xiaojun Yao, Jue Wang, Chun Xie, Zebo Jiang, Weixing Shen and Jumin Huang. Their work appears in journals such as Phytomedicine, Pharmacological Research, Journal of Cancer, Medicine and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026